S. Vig

Hydroxytriamides as potent gamma-secretase inhibitors.

Jeffrey W. Noonan, David W. Smith, D. Barten, 2004, Bioorganic & medicinal chemistry letters.

2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase

David W. Smith, D. Barten, C. Polson, 2004 .

Further examples of para- and ortho-disubstituted benzene derivatives reduced in a reversible two-electron step into products of limited stability

P. Zuman, S. Vig, O. Manoušek, 1968 .

Synthesis and structure-activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists.

J. Macor, G. Trainor, H. Wong, 2012, Bioorganic & medicinal chemistry letters.

Stereoselective synthesis of a versatile intermediate for the total synthesis of mono- and bis-THF containing annonaceous acetogenins

F. Uckun, Keqiang Li, S. Vig, 1999 .

Stereocontrolled synthesis of the tetrahydrofuran unit of annonaceous acetogenins

F. Uckun, Keqiang Li, S. Vig, 1998 .

Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): a gamma-secretase inhibitor with Abeta lowering activity in a transgenic mouse model of Alzheimer's disease.

David W. Smith, J. Hendrick, D. Barten, 2007, Bioorganic & medicinal chemistry letters.

Hydroxytriamides as potent γ-secretase inhibitors

Jeffrey W. Noonan, David W. Smith, D. Barten, 2004 .